A detailed history of Carolinas Wealth Consulting LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Carolinas Wealth Consulting LLC holds 10,708 shares of ABBV stock, worth $1.82 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
10,708
Previous 10,247 4.5%
Holding current value
$1.82 Million
Previous $1.76 Million 20.32%
% of portfolio
0.37%
Previous 0.32%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $75,530 - $91,891
461 Added 4.5%
10,708 $2.11 Million
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $338,835 - $395,683
2,189 Added 27.17%
10,247 $1.76 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $2.48 Million - $2.82 Million
-15,488 Reduced 65.78%
8,058 $1.47 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $20,915 - $23,555
152 Added 0.65%
23,546 $3.65 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $16,698 - $19,331
125 Added 0.54%
23,394 $3.49 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $86,131 - $107,185
-650 Reduced 2.72%
23,269 $3.14 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $56,108 - $64,617
388 Added 1.65%
23,919 $3.81 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $442,038 - $530,120
3,196 Added 15.72%
23,531 $3.81 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $39,055 - $44,793
-291 Reduced 1.41%
20,335 $675,000
Q2 2022

Aug 16, 2022

BUY
$137.62 - $174.96 $2.08 Million - $2.64 Million
15,086 Added 272.31%
20,626 $812,000
Q1 2022

May 17, 2022

BUY
$131.98 - $163.75 $19,005 - $23,580
144 Added 2.67%
5,540 $898,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $61,987 - $78,431
577 Added 11.97%
5,396 $731,000
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $111,932 - $127,060
-1,052 Reduced 17.92%
4,819 $520,000
Q2 2021

Aug 17, 2021

BUY
$105.21 - $117.21 $78,171 - $87,087
743 Added 14.49%
5,871 $661,000
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $54,321 - $59,801
531 Added 11.55%
5,128 $555,000
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $67,450 - $91,065
838 Added 22.29%
4,597 $493,000
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $36,339 - $42,651
423 Added 12.68%
3,759 $329,000
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $807 - $1,079
11 Added 0.33%
3,336 $328,000
Q1 2020

May 11, 2020

BUY
$64.5 - $97.79 $214,462 - $325,151
3,325 New
3,325 $253,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Carolinas Wealth Consulting LLC Portfolio

Follow Carolinas Wealth Consulting LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.